Objective: This study aimed to investigate the effects of addiction to morphine and nicotine as well as their withdrawal on both barorefl ex sensitivity and blood pressure in hypertensive rats. Methods: In this experimental study 40 male rats were divided into two main groups as follows: in group I, hypertensive rats received saline for 8 weeks; in group II, hypertensive rats were treated with morphine and nicotine for 8 weeks. At the end of 8 weeks group II rats were divided into four sub-groups including, 3 sub-groups of those were put on drug withdrawal protocol. At the end of experiment, blood pressure, heart rate, plasma renin activity (PRA), serum NO concentration and barorefl ex sensitivity (BRS) were measured. Results: Results demonstrated that BP and BRS were signifi cantly lower in addicted to morphine and nicotine hypertensive rats compared to control (p < 0.05). Addiction withdrawal (in morphine and nicotine withdrawal rats) completely reversed BP and BRS to the pre-addiction levels (p < 0.05). Withdrawal in the only nicotine treated group lowered BP and BRS compared to group that had received morphine and nicotine together (p < 0.05). Conclusion: Results of current study may propose simultaneous morphine and nicotine withdrawal can prevent cardiovascular complications raised due to withdrawal (Fig. 5, Ref. 58 ). Text in PDF www.elis.sk.
The arterial barorefl ex is defi ned as one of the most important physiological mechanisms involves in homeostasis of blood pressure (BP) (1) . Barorefl ex sensitivity (BRS) damage is a marker of autonomic dysfunction and plays a major role in the long-term development of arterial hypertension and related complications (2) . It a pears that the function of arterial barorefl ex is involved in the regulation of cardiovascular function (3, 4) . Simultaneous elevated sympathetic nervous system and renin-angiotensin-aldosterone system modulates several biological changes including vascular changes, arterial stiffness, and increased BP eventually causing myocardial hypertrophy (5). Which further incorporate to a vicious cycle of hypertension and related complications. The baroreceptor refl ex serves blood pressure buffer system for damping short-term variations of arterial pressure (1) . Due to their complex rest in any new MAP baroreceptors have minor importance on chronic (6). On this light evidences indicated that long-term morphine addiction may change the performance of these centers. Morphine in parallel with peripheral vasodilatation down-regulate systemic blood pressure (BP). This property of morphine is accompanied by inhibition of baroreceptor and depressed respiratory refl exes and sometimes causes cardiac arrest as well as respiratory problems (7). It assumed that the opioid actioncenter is located at the brain stem at primary baroreceptor synapses in the nucleus of the solitary tract. This region is concentrated with opioid containing fi bers and opiate receptors (8, 9). The BP, systemic vascular resistance and heart rate show acute and prolonged increases induced by cigarette smoking (10, 12). This happens following stimulation of the adrenaline and noradrenalin release in the sympathetic nerve system by nicotine (10, 12). Thus, a generalized peripheral adrenergic receptors stimulation is possibly in charge of the acute cardiovascular effects of smoking (13, 14). The impaired arterial baroreceptor function and other multiple factors, elevate associated cardiovascular risk factors of smoking (15). It is now well evidenced that the risk of cardiovascular diseases reduce immediately after leaving of cigarette smoking (16). Changes BP, heart rate (HR), and autonomic nervous function are thought to be at least in part responsible for the rapid reduction in the risk of cardiovascular diseases subsequent to quitting (17).
Due to the changes in BRS during hypertension (18), administration of morphine (19) and nicotine (20). May be useful Thus, the aim of this study was to evaluate the effect of chronic hypertension and concurrent administration of morphine and nicotine on BRS and BP and investigate whether if withdrawal of morphine and nicotine effect on improve of barorefl exe sensitivity and blood pressure. We asked whether if cardiovascular disorders are raised by simultaneous withdrawal of morphine and nicotine or these compounds act independently to run these disorders.
Material and methods

Animals
Forty male Wistar rats (aged 10-12 weeks old and weighting 200-250 g) were purchased from Pasteur Institute of Iran. Rats were kept in animal house with 12 h light/dark cycle and a temperature of 20-25 °C. The animals had free access to tap water and commercial rat chow during experiment. Of period Ethical committee of Rafsanjan University of Medical Sciences approved the study protocol.
Experimental protocol
Following one week of getting familiar with animal house, male hypertensive rats were randomly divided in to two groups as follows: Group (1): received solvent of saline for 8 weeks via injection (n = 8); Group (2): received 3 mg/kg of morphine and 0.01 mg/kg of nicotine 8 weeks via injection (n = 32). At the end of 8 weeks groups (2) were divided into 4 sub-groups that 3 subgroups (n = 24) of those fi t in drug withdrawals. The fi rst sub-group was only starved from morphine (n = 8). Second sub-group was only starved from nicotine (n = 8). The third sub-group was started from both morphine and nicotine (n = 8). Subsequent to 24 hours of withdrawal, naloxone (2 mg/kg) was injected. The withdrawal signs (body shakes, jumping, climbing, writhing, teeth chattering, irritability, ejaculation, ptosis and diarrhea) within 30 min after the injections of naloxone were evaluated.
Induction of hypertension with 2K1C goldblatt method
Initially rats were anesthetized using intraperitoneally ketamine hydrochloride (60 mg/kg) and xylazine (7.5 mg/kg). The left kidney was exposed via fl ank incision and a silver clip with an internal gap of 0.2 mm was located around the renal artery. To control the risk of infections, rats received a profi lactic dose of penicillin G (25000 IU/rat) after surgery. Systolic and diastolic blood pressure was measured once a week by a tail-cuff plethysmography under light ether anesthesia. At the end of 8 weeks treatment, animals were anesthetized and direct blood pressure was measured by a catheter (PE50) which was inserted into femoral artery.
Plasma renin activity
The PRA was measured using Gamma coat PRA Radioimmunoassay kit (DiaSorinInc). PRA was measured after withdrawal in hypertensive rats.
Serum NO measurement
Serum NO concentrations were measured by Griess reagentkit (Promega, Madison, WI, Cat#G2930) by spectrophotometer at a wavelength of 540 nm using standard curve as previously described (21).
Barorefl ex test
The barorefl ex was tested with a press or dose of phenylephrine (PE-bolus-8 μg/kg IV; Sigma Chemical) (22). The barorefl ex was calculated as the derivation of HR in function of the MAP variation (ΔHR/ΔMAP) (23). There was an interval of at least 15 minutes between the infusions to allow the recovery of basal values (18).
Statistical analysis
We applied one-way ANOVA for comparison of data between groups. Data are reported as mean ± SE. p value less than 0.05 was considered signifi cant.
Result
Evaluation of blood pressure and heart rat
The systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) measurement in hypertensive rats showed that co-administration of morphine and nicotine in hypertensive rats signifi cantly reduced BP in study groups when compared with control (p < 0.05). In addicted rats withdrawal (specifi c in morphine + nicotine withdrawal) compared to nicotine withdrawal and co-administration of morphine and nicotine completely reversed BP to control group level (p < 0.05) (Fig 1) . HR was not signifi cantly differed between groups (Fig 2) .
Measurement of PRA
The PRA levels were decrees in nicotine withdrawal animals compared to control (p < 0.05) (Fig. 3) . 
Serum NO concentration
The serum NO concentration in co-administration group (morphine and nicotine) was not different compared to control. But serum NO concentrationwas increased in nicotine withdrawal animals compared to control (p < 0.05) (Fig. 4) .
BRS
In hypertensive rats that received contemporary of morphine and nicotine during 8 weeks, BRS was decrees compared to control, morphine withdrawal and morphine + nicotine withdrawal and nicotine withdrawal (p < 0.05) and addict withdrawal specifi c in morphine + nicotine withdrawal compared to nicotine withdrawal completely reversed BRS to control group level (p < 0.05) (Fig. 5) .
Discussion
Previous investigations revealed that analysis of arterial pressure and HR are both important indices of barorefl ex sensitivity (24, 25). In the present report we used cardiovascular markers including BP and HR up to provide a means of objective and continuous assessment effects of the co-administration of morphine and nicotine and those withdrawal on the BRS.
Current results evidently showed that blood pressure was signifi cantly reduced in morphine and nicotine addicted hypertensive rats. The addiction withdrawal particular in morphine + nicotine withdrawal compl etely reversed blood pressure to control level, while during nicotine withdrawal the BP remained at low level. But it did not signifi cantly affected HR.
Likewise the previous reports reduced BP following prolonged application of low-dose morphine in 2K1C animals might probably be due to decreased PRA levels (26). Some other research teams claimed that administration of chronic morphine decreases baseline cardiovascular parameters MAP and HR. following morphine withdrawal, and naloxone injection in morphine-treated rats, an increased MAP, HR (27), SBP and DBP was observed (28, 29). This was also occurred in case of nicotine consumption and increased HR, SBP, DBP, and MAP is visible (30). Increase BP after administration of nicotine may be related to increase PRA level (31). The BRS is an independent risk factor for morbidity and major adverse cardiovascular event in patients suffering hypertension (32) and it appears to be an integral predictor for future cardiovascular events in patients with arterial hypertension (33). Evidences are in favors of the fact that hypertension is connected with decreased BRS (32, 34) and a signifi cant negative correlation between presents BRS and BP (1).
We also evaluated BRS and found that morphine and nicotine addiction in hypertensive rats reduced BRS and morphine + nicotine withdrawal completely reversed it to the control level, while in case of nicotine withdrawal was remained at low level.
Serum NO levels were not differed between morphine and nicotine addicted hypertensive rats and it was sustained unchanged following control group, and addiction withdrawal.
Autonomous nervous dysfunction and inappropriately active sympathetic nervous system in patients with arterial hypertension is an important etiopathogenetic factor that contributes also to progression of disease, and the resultant cardiovascular risk. the BRS as a marker of autonomic dysfunction adding as a method for identifying patients at high cardiovascular risk (1).
Recent investigations described a relationship between NO and barorefl ex function in hypertensive rats (35).
NOis an important biological modulator with diverse physiological activities that include vaso-relaxation (36-38). NO is derived from the action of NO synthase (NOS) on its substrate, L-arginine. NO modulates vascular tone directly by relaxing vascular smooth muscle (39) and indirectly by restraining central sympathetic outfl ow (40) and NE release from nerve terminals (41). Overall, NO has been shown to have sym-central and peripheral mechanisms (42).
No have an important role in the autonomic nervous system regulating HR and especially, arterial pressure variability (43). NO had been postulated to be a modulator of sympathetic nerve activity, decreasing peripheral sympathetic nerve activity (44). It is proposed that NO can affect barorefl ex via other factors. such as neural pathways (45) or pathophysiological conditions (44). These fi ndings are in accordance with the paradigm that blood pressure variability is not the direct result of unbuffered variations in sympathetic discharge but, rather, is produced by an interaction between neural and humoral components (46) .
Previous evidences in hypertensive rats offering a mechanism by which that neuronal NO production is impaired at a number of key central sites concerned with autonomic cardiovascular regulation (42).
Studies are also indicative that morphine affects peripheral or central BRS modulation (47) . Endogenous and exogenous opioids regulate the performance of BRS throughout infl uencing central opioids receptors, including Mu and Kappa (48) .
Other studies are demonstrating that acute and chronic injection of morphine signifi cantly reduces SBP, DBP and MAP. Moreover, it signifi cantly upregulates the sensitivity of barorefl exes (19). The BP increased more rapidly following administration of nicotine in hypertensive rats (47) . So that nicotine causes induced BP and HR in parallel with impaired barorefl ex sensitivity (15). In patients with cardiovascular disease who showing impaired BRS, such as patients with hypertension (49) and heart failure (50) , impaired barorefl ex function may leading signifi cant tachycardia and sympathetic activation during cigarette smoking (51) . Smoking of cigarette increases the activity of the autonomic nervous system (the sympathetic part), increases HR , BP and impairs the barorefl ex (52, 53) . The mechanism of increasing BP and HR by nicotine is believed to be regulated by activation of the sympathetic nervous system with a release of nor epinephrine and epinephrine (54) ,vasopressin release (55), or by affecting endothelial function (56) . Chronic nicotine impairs endothelial function by decreasing the formation of NO and increasing the NO degradation via generation of free oxygen radicals (57) while nicotine cessation reverses smoking induced endothelial dysfunction (58). In concluding the BP and BRS are signifi cantly reduced during morphine and nicotine addiction in hypertensive rat our proposed model however, serum NO level did failed to change. We found that withdrawal not improve serum NO concentration while BP and BRS achieved to its basal level pre administration of morphine and nicotine. Overall, with peripheral mechanisms could not modulate changes of BP and BRS. Thus, it seems that in addition to morphine and nicotine and those withdrawals other mechanisms could be involved in regulation of BP and BRS. Therefore, it might be suggested that during addiction and withdrawal number of key central sites concerned with autonomic cardiovascular regulation in regulation of BP and BRS is important. 
